Navigation Links
Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat

e CA-SP1 junction and has been observed previously in bevirimat resistance generation studies. The CSHL conference presentation concluded that bevirimat resistance may be less likely to arise in PI-resistant HIV strains.

Dr. Graham P. Allaway, Panacos' President and Chief Operating Officer commented, "Clinical studies to date suggest resistance to bevirimat does not develop rapidly, in contrast to some currently marketed HIV drugs, possibly because there is selective pressure to maintain the integrity of the capsid-SP1 cleavage site sequence, which is highly conserved among HIV strains. While resistance tends to develop eventually to all HIV inhibitors, the new study suggests there may be a greater hurdle to bevirimat resistance development in patients with PI-resistant virus. These patients represent one of the major groups who could potentially benefit from novel-mechanism HIV drugs such as bevirimat."

About Panacos

Panacos is developing the next generation of anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. HIV infects approximately 1.7 million people in North America and Western Europe and approximately 40 million people worldwide. Approximately 650,000 patients are treated annually for HIV in the United States and Western Europe. Resistance to currently available drugs is one of the most pressing problems in HIV therapy and the leading cause of treatment failure. Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion.

Panacos' lead candidate, bevirimat (PA-457), is the first in a new class of oral HIV therapeutics under development called maturation inhibitors, discovered by Panacos scientists and their academic collaborators. Based on its novel mechanism of action, bevirimat is designed to have potent activity agai
'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:7/25/2014)... Kan. , July 25, 2014 /PRNewswire-iReach/ -- ... and TCGRx, of Powers Lake, Wisconsin ... partners in a distribution and co-marketing agreement allowing ... retail pharmacies throughout the United States ... robotics-based pharmacy management and workflow systems to retail ...
(Date:7/25/2014)... , July 25, 2014 Cardinal Health will ... pharmacies as winners of its prestigious Independent Pharmacy Best ... , one of the nation,s largest gatherings of independent ... – family-owned pharmacies from Ohio , ... – were selected for implementing exceptionally creative ...
(Date:7/25/2014)... DUBLIN , July 25, 2014 ... the "Global Ophthalmic Diagnostic Devices Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 About Ophthalmic Diagnostic Device ... device used to identify a defect or deficiency in ... patients with ophthalmic disorders such as presbyopia, cataracts, glaucoma, ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... presented at NACFC and ICAAC/IDSA meetings this week, ... Inc. today,announced additional clinical and preclinical results with ... delivered by,an Investigational eFlow Nebulizer System for use ... (COPD). Clinical results show,that aerosol dosing of MP-376 ...
... 23 , - First Responses in Solid ... role in cell duplication and are,implicated in both ... tumour. A,lecture focusing on Aurora kinase inhibitors will ... 20th EORTC-NCI-AACR Symposium "Molecular,Targets and Cancer Therapeutics" organised ...
Cached Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 3
(Date:7/26/2014)... (PRWEB) July 26, 2014 According to ... Vkool.com, this is a comprehensive guide that covers detailed ... (KP) effectively without the need of any medication. ... consists of natural and safe remedies for relieving symptoms ... people will learn:,     How to treat ...
(Date:7/26/2014)... The birth control safety center at ... of new legal information on the site. A federal ... of lawsuits pending for July alleging side effects from ... those using popular prescription drugs and medical devices. By ... legal news all in one place, they can see ...
(Date:7/25/2014)... 2014 2014 Deep Research ... Chromatography Industry” is a professional and in-depth ... Gel Permeation Chromatography market. The report provides ... Permeation Chromatography definition, classification, application, and industry ... This research covers the international market analysis, ...
(Date:7/25/2014)... According to a new market ... (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, ... and Geography - Global Forecast to 2014 - ... market is expected to reach $2.50 at a ... Browse 117 market data Tables and 57 Figures ...
(Date:7/25/2014)... July 25, 2014 As reported by the ... War On Heroin (7/20), police in Salem, MA as ... down on the recent heroin epidemic that has taken many ... on one heroin-related overdose case in which police were able ... victim's cell phone. By pretending to be the victim and ...
Breaking Medicine News(10 mins):Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Multiple States Crack Down on Heroin Epidemic 2
... Although it is now common knowledge that breast-feeding gives ... has found that babies who are breast-fed beyond none ... feeding for up to six months is known to ... extending exclusive breast-feeding beyond six months may increase the ...
... Caledonian University have found that almost one in 10 ... survey of more than 2,000 students studying //in west-central ... aged between 13-16 demonstrated behaviors that could lead to ... group of 11-12 years, 6 percent of the children ...
... Medical School and his team has carried out research on ... occurs only in one in a million births. “About 1,500 ... injections to survive” says Dr. Pearson. According to him neonatal ... will help in controlling the blood sugar levels more effectively. ...
... due to its eradication, yet people could still be susceptible ... says a recent report.// ,Researchers recalled the ... an unvaccinated teenager contracted the virus and innocently passed it ... a large outbreak in USA, which also caused a financial ...
... released a 10-year ‘action plan’ for improving the services and ... ,It was reported that the N.Zealand, Health Minister Pete Hodgson ... part of the work was to ensure that patients with ... earlier by way of a large range of services. ...
... an alarm clock that promises to wake its users up when ... Sleep Phase Alarm Clock checks 30 minutes before the alarm is ... or light phase of sleep, say the manufacturers Infacory Innovations, who ... recently in Munich. ,With the help of a sensor ...
Cached Medicine News:Health News:Painless Control Of Blood Sugar Levels When Detected Early 2
... the art software package designed to assist in ... by a lens manufacturer with years of experience ... is designed to help you run your lab ... the software dictates., ,Designed specifically for integrated retail ...
... The table-mounted knee retractor ... for total knee arthroplasty ... open-frame design allows for ... knee during the procedure. ...
... for every general surgery need. No matter ... the GO550/GO500 Omni-Flex General Retractor Systems give ... simplest way possible., ,With large and small ... arm, the GO550 provides comprehensive flexibility and ...
... sounds you need to hear! ... body sounds while reducing distracting ... Model 3000., ,With Ambient Noise ... 18 times amplification, and a ...
Medicine Products: